Why BioNTech Crushed the Market on Monday

Recently minted biotech industry star BioNTech (NASDAQ: BNTX) was a standout performer on Monday. The stock closed 8.5% higher on the day thanks to very encouraging remarks uttered by its CEO regarding the coronavirus vaccine it's developed with Pfizer (NYSE: PFE). 

As many are aware, BioNTech/Pfizer's BNT162b2 was recently authorized for emergency use in both the U.S. and European Union. On Monday, the biotech's CEO, Dr. Ugur Sahin, made several hopeful pronouncements about it.

Image source: Getty Images.

Continue reading

Source Fool.com